Research led by the New York State Psychiatric Institute, New York, has looked into non-medical lysergic acid diethylamide (LSD) use by people with major depression status and their ...

For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering ...

Health Secretary Robert F. Kennedy Jr. and other Trump officials are signaling their interest in approving psychedelic drugs ...

A study from the New York State Psychiatric Institute reveals a 450% increase in non-medical LSD use among US adults with major depression, emphasizing the need for informed, safe use.

Psychedelics like ketamine and LSD straddle a fine line—offering therapeutic promise under medical supervision, yet posing serious health risks when trafficked through darknet syndicates for personal ...

A single oral administration of an LSD-based medicine provided rapid and durable improvement in moderate to severe generalized anxiety disorder (GAD) in a phase 2B study.

President Donald Trump has signed a fentanyl crackdown bill championed by New Mexico Senator Martin Heinrich (D). The Halt ...